They are a pharma co, that got tossed to the pinks because they have not been able to file on time. Financials are being restated, so not sure if reliable, but the last audited fin'l have them generating $116mm rev (9/04) for the first 9 months and a loss of .46. Not very good numbers, but I found the letter from a dissident shareholder very encouraging. Because mgmt has been a bit inept, a large dissident shareholder has moved to shakeup the executive board to explore alternatives. Enclosed is the filing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.